This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Ciarra Chavarria
Ciarra A. Chavarria
New York +1 212 841 1112 Download V-card

Ciarra Chavarria advises clients across a broad range of corporate and securities law matters. Her practice focuses on the representation of underwriters and issuers in capital markets transactions as well as regularly advising clients on securities compliance and regulatory matters, SEC reporting, corporate governance and other corporate matters.

  • Represents clients in designing and implementing exchange- and SEC-compliant corporate governance policies and practices.
  • Represented the underwriters in a $150 million initial public offering and $215 million follow-on public offering of a biopharmaceutical company that genetically engineers a cancer patient’s T cells to recognize and destroy cancer cells.
  • Represented a commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions in a $60 million public offering.
  • Advised a leading developer, manufacturer, and marketer of life science tools and systems for genetic analysis in a proxy contest in connection with a hostile takeover bid by a large pharmaceutical company.
  • Represented the underwriters in a public offering of a developer and commercial supplier of a diversified portfolio of advanced drug delivery systems.
  • Represented the underwriters in the $130 million public offering of a specialty pharmaceutical company focused on gastrointestinal disorders.
  • Represented the underwriters in a $500 million public offering of investment-grade notes and common stock of a large financial services firm.
  • Represented the underwriters in the $100 million, accelerated book-build/wall-cross public offering of American Depositary Shares of a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease

Pro Bono

  • Assisted not-for-profit organizations incorporate and obtain tax exempt status.
  • Provided ongoing legal services and advice to a not-for-profit organization that provides literacy education support to adults, out-of-school youths and families.
  • Advised governments and civil society organizations on a variety of public international law matters, including atrocity crimes in various country law, constitution-drafting, protection of minority rights, hybrid tribunal practice, sexual and gender-based violence as an international crime, and anti-corruption.
  • Represented Holocaust survivors in obtaining pensions from the German government.
  • Represented a not-for-profit arts education organization in its reincorporation as a New York not-for-profit corporation.